United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 6 minute read General business news Rollins Inc share sale and buyback: how the dual move could reshape market confidence Rollins Inc launches a $1 billion secondary stock sale alongside a $200 million buyback. Find out how this strategic pairing could reshape investor sentiment. bySoujanya RaviNovember 11, 2025